创伤性脑损伤继发凝血病的相关研究进展
Research Progress of Coagulopathy Secondary to Traumatic Brain Injury
DOI: 10.12677/acm.2025.153745, PDF,   
作者: 贺一雄*：右江民族医学院研究生学院，广西 百色；沈 印#：广西骨伤医院，广西 南宁
关键词: 创伤性脑损伤；凝血功能紊乱；纤维蛋白原；内皮糖萼；Traumatic Brain Injury； Coagulation Disorders； Fibrinogen； Endothelial Glycocalyx
摘要: 创伤性脑损伤(Traumatic Brain Injury, TBI)是指外力对大脑造成的损伤，由直接创伤因素以及间接创伤因素构成，直接创伤是以车祸、摔倒等外伤为主所导致，而间接创伤因素则是以运动、娱乐等造成大脑反复的变速运动所导致。TBI是我国创伤主要的致残、致死原因之一，尤其是以青、中年男性以及儿童为主的群体。TBI后，纤维蛋白溶解的亢进以及血小板功能的异常等过程，都将导致凝血功能发生紊乱，凝血功能紊乱不只是出血时间的延长和出血增多的低凝血功能障碍，还包含有静脉血栓形成风险增大的高凝血功能障碍。由于TBI引起的继发性脑损伤机制的复杂性以及高、低凝血功能障碍的矛盾性，都使得临床医师对患者治疗的方案及时机难以统一，因此本文旨在将TBI继发性凝血病的发生机制、检测方式和治疗进行综述，为临床治疗方法提供参考并改善患者预后。
Abstract: Traumatic Brain Injury (TBI) refers to the injury to the brain caused by external forces, which is composed of direct traumatic factors and indirect trauma factors. Direct traumatic factors are mainly caused by traumatic injuries such as car accidents and falls, while indirect trauma factors are caused by repeated variable speed movements of the brain caused by sports and entertainment. TBI is one of the main causes of disability and death in China, especially among young and middle-aged men and children. After TBI, hyperfibrinolysis and abnormal platelet function will lead to coagulation disorders, which are not only hypocoagulant dysfunction due to prolonged bleeding time and increased bleeding, but also hypercoagulant dysfunction with increased risk of venous thrombosis. Due to the complexity of the mechanism of secondary brain injury caused by TBI and the contradiction between high and low coagulation dysfunction, it is difficult for clinicians to unify the treatment plan and timing of patients, so this article aims to review the mechanism, detection and treatment of coagulation disease secondary to TBI, so as to provide a reference for clinical treatment methods and improve the prognosis of patients.
文章引用：贺一雄, 沈印. 创伤性脑损伤继发凝血病的相关研究进展[J]. 临床医学进展, 2025, 15(3): 1323-1329. https://doi.org/10.12677/acm.2025.153745

参考文献

[1] Silvestre-Roig, C., Braster, Q., Ortega-Gomez, A. and Soehnlein, O. (2020) Neutrophils as Regulators of Cardiovascular Inflammation. Nature Reviews Cardiology, 17, 327-340. [Google Scholar] [CrossRef] [PubMed]
[2] Caillon, A., Trimaille, A., Favre, J., Jesel, L., Morel, O. and Kauffenstein, G. (2022) Role of Neutrophils, Platelets, and Extracellular Vesicles and Their Interactions in COVID-19-Associated Thrombopathy. Journal of Thrombosis and Haemostasis, 20, 17-31. [Google Scholar] [CrossRef] [PubMed]
[3] Nakae, R., Murai, Y., Morita, A. and Yokobori, S. (2022) Coagulopathy and Traumatic Brain Injury: Overview of New Diagnostic and Therapeutic Strategies. Neurologia Medico-Chirurgica (Tokyo), 62, 261-269. [Google Scholar] [CrossRef] [PubMed]
[4] van Gent, J.A.N., van Essen, T.A., Bos, M.H.A., Cannegieter, S.C., van Dijck, J.T.J.M. and Peul, W.C. (2019) Coagulopathy after Hemorrhagic Traumatic Brain Injury, an Observational Study of the Incidence and Prognosis. Acta Neurochirurgica, 162, 329-336. [Google Scholar] [CrossRef] [PubMed]
[5] Epstein, D.S., Mitra, B., O’Reilly, G., Rosenfeld, J.V. and Cameron, P.A. (2014) Acute Traumatic Coagulopathy in the Setting of Isolated Traumatic Brain Injury: A Systematic Review and Meta-Analysis. Injury, 45, 819-824. [Google Scholar] [CrossRef] [PubMed]
[6] Maegele, M., Schöchl, H., Menovsky, T., Maréchal, H., Marklund, N., Buki, A. and Stanworth, S. (2017) Coagulopathy and Haemorrhagic Progression in Traumatic Brain Injury: Advances in Mechanisms, Diagnosis, and Management. The Lancet Neurology, 16, 630-647. [Google Scholar] [CrossRef] 
[7] Maegele, M. (2021) Coagulopathy and Progression of Intracranial Hemorrhage in Traumatic Brain Injury: Mechanisms, Impact, and Therapeutic Considerations. Neurosurgery, 89, 954-966. [Google Scholar] [CrossRef] [PubMed]
[8] Winter, W.E., Flax, S.D. and Harris, N.S. (2017) Coagulation Testing in the Core Laboratory. Laboratory Medicine, 48, 295-313. [Google Scholar] [CrossRef] [PubMed]
[9] Mast, A.E. and Ruf, W. (2022) Regulation of Coagulation by Tissue Factor Pathway Inhibitor: Implications for Hemophilia Therapy. Journal of Thrombosis and Haemostasis, 20, 1290-1300. [Google Scholar] [CrossRef] [PubMed]
[10] Sajadi, S., Ezekowitz, M.D., Dhond, A. and Netrebko, P. (2003) Tissue Factor Pathway Inhibitors as a Novel Approach to Antithrombotic Therapy. Drug News & Perspectives, 16, 363-369. [Google Scholar] [CrossRef] [PubMed]
[11] Kobayashi, H., Matsubara, S. and Imanaka, S. (2023) The Role of Tissue Factor Pathway Inhibitor 2 in the Coagulation and Fibrinolysis System. The Journal of Obstetrics and Gynaecology Research, 49, 1677-1683. [Google Scholar] [CrossRef] [PubMed]
[12] Hoppe, B. (2014) Fibrinogen and Factor XIII at the Intersection of Coagulation, Fibrinolysis and Inflammation. Thrombosis and Haemostasis, 112, 649-658. [Google Scholar] [CrossRef] 
[13] Bennett, J.S. (2001) Platelet-Fibrinogen Interactions. Annals of the New York Academy of Sciences, 936, 340-354. [Google Scholar] [CrossRef] [PubMed]
[14] Nakae, R., Fujiki, Y., Takayama, Y., Kanaya, T., Igarashi, Y., Suzuki, G., Naoe, Y. and Yokobori, S. (2020) Age-Related Differences in the Time Course of Coagulation and Fibrinolytic Parameters in Patients with Traumatic Brain Injury. International Journal of Molecular Sciences, 21, Article 5613. [Google Scholar] [CrossRef] [PubMed]
[15] Nakae, R., Takayama, Y., Kuwamoto, K., Naoe, Y., Sato, H. and Yokota, H. (2016) Time Course of Coagulation and Fibrinolytic Parameters in Patients with Traumatic Brain Injury. Journal of Neurotrauma, 33, 688-695. [Google Scholar] [CrossRef] [PubMed]
[16] Ebrahimi, S., Jaberi, N., Avan, A., Ryzhikov, M., Keramati, M.R., Parizadeh, M.R. and Hassanian, S.M. (2017) Role of Thrombin in the Pathogenesis of Central Nervous System Inflammatory Diseases. Journal of Cellular Physiology, 232, 482-485. [Google Scholar] [CrossRef] [PubMed]
[17] Luyendyk, J.P., Schoenecker, J.G. and Flick, M.J. (2019) The Multifaceted Role of Fibrinogen in Tissue Injury and Inflammation. Blood, 133, 511-520. [Google Scholar] [CrossRef] [PubMed]
[18] Petersen, M.A., Ryu, J.K. and Akassoglou, K. (2018) Fibrinogen in Neurological Diseases: Mechanisms, Imaging and Therapeutics. Nature Reviews Neuroscience, 19, 283-301. [Google Scholar] [CrossRef] [PubMed]
[19] Hosseininejad, S.M., Bozorgi, F., Jahanian, F., Mohammadian Amiri, M., Mohammadpour, R.A. and Hajiaghaei, G. (2023) C-Reactive Protein and D-Dimer as Prognostic Markers for Clinical Outcomes in Patients with Mild Traumatic Brain Injury: A Cross-Sectional Study. Bulletin of Emergency and Trauma, 11, 119-124.
[20] Zhang, J., He, M., Song, Y. and Xu, J. (2018) Prognostic Role of D-Dimer Level upon Admission in Patients with Traumatic Brain Injury. Medicine (Baltimore), 97, e11774. [Google Scholar] [CrossRef] 
[21] Jedlicka, J., Becker, B.F. and Chappell, D. (2020) Endothelial Glycocalyx. Critical Care Clinics, 36, 217-232. [Google Scholar] [CrossRef] [PubMed]
[22] Foote, C.A., Soares, R.N., Ramirez-Perez, F.I., Ghiarone, T., Aroor, A., Manrique-Acevedo, C., Padilla, J. and Martinez-Lemus, L. (2022) Endothelial Glycocalyx. Comprehensive Physiology, 12, 3781-3811. [Google Scholar] [CrossRef] [PubMed]
[23] Rahbar, E., Cardenas, J.C., Baimukanova, G., Usadi, B., Bruhn, R., Pati, S., Ostrowski, S.R., Johansson, P.I., Holcomb, J.B. and Wade, C.E. (2015) Endothelial Glycocalyx Shedding and Vascular Permeability in Severely Injured Trauma Patients. Journal of Translational Medicine, 13, Article No. 117. [Google Scholar] [CrossRef] [PubMed]
[24] Nieuwdorp, M., Meuwese, M.C., Mooij, H.L., van Lieshout, M.H., Hayden, A., Levi, M., Meijers, J.C., Ince, C., Kastelein, J.J., Vink, H. and Stroes, E.S. (2009) Tumor Necrosis Factor-Alpha Inhibition Protects against Endotoxin-Induced Endothelial Glycocalyx Perturbation. Atherosclerosis, 202, 296-303. [Google Scholar] [CrossRef] [PubMed]
[25] Hall, A.A., Mendoza, M.I., Zhou, H., Shaughness, M., McCarron, R.M. and Ahlers, S.T. (2019) Corrigendum: Repeated Low Intensity Blast Exposure Is Associated with Damaged Endothelial Glycocalyx and Downstream Behavioral Deficits. Frontiers in Behavioral Neuroscience, 13, Article 251. [Google Scholar] [CrossRef] [PubMed]
[26] Washington, P.M., Lee, C., Dwyer, M.K.R., Konofagou, E.E., Kernie, S.G. and Morrison, B. (2020) Hyaluronidase Reduced Edema after Experimental Traumatic Brain Injury. Journal of Cerebral Blood Flow & Metabolism, 40, 2026-2037. [Google Scholar] [CrossRef] 
[27] Yu, J., Zhu, H., Taheri, S., Monday, W.L., Perry, S. and Kindy, M.S. (2019) Reduced Neuroinflammation and Improved Functional Recovery after Traumatic Brain Injury by Prophylactic Diet Supplementation in Mice. Nutrients, 11, Article 299. [Google Scholar] [CrossRef] [PubMed]
[28] Tomaiuolo, M., Brass, L.F. and Stalker, T.J. (2017) Regulation of Platelet Activation and Coagulation and Its Role in Vascular Injury and Arterial Thrombosis. Interventional Cardiology Clinics, 6, 1-12. [Google Scholar] [CrossRef] [PubMed]
[29] Daley, M.J., Enright, Z., Nguyen, J., Ali, S., Clark, A., Aydelotte, J.D., Teixeira, P.G., Coopwood, T.B. and Brown, C.V. (2017) Adenosine Diphosphate Platelet Dysfunction on Thromboelastogram Is Independently Associated with Increased Morality in Traumatic Brain Injury. European Journal of Trauma and Emergency Surgery, 43, 105-111. [Google Scholar] [CrossRef] [PubMed]
[30] Brown, L.M., Call, M.S., Margaret Knudson, M., Cohen, M.J. the Trauma Outcomes Group (2011) A Normal Platelet Count May Not Be Enough: The Impact of Admission Platelet Count on Mortality and Transfusion in Severely Injured Trauma Patients. The Journal of Trauma: Injury, Infection, and Critical Care, 71, S337-S342. [Google Scholar] [CrossRef] 
[31] Van Beek, J.G., Mushkudiani, N.A., Steyerberg, E.W., Butcher, I., McHugh, G.S., Lu, J., Marmarou, A., Murray, G.D. and Maas, A.I. (2007) Prognostic Value of Admission Laboratory Parameters in Traumatic Brain Injury: Results from the IMPACT Study. Journal of Neurotrauma, 24, 315-328. [Google Scholar] [CrossRef] [PubMed]
[32] Sun, P., McMillan-Ward, E., Mian, R. and Israels, S.J. (2019) Comparison of Light Transmission Aggregometry and Multiple Electrode Aggregometry for the Evaluation of Patients with Mucocutaneous Bleeding. International Journal of Laboratory Hematology, 41, 133-140. [Google Scholar] [CrossRef] [PubMed]
[33] Riojas, C.M., Ekaney, M.L., Ross, S.W., Cunningham, K.W., Furay, E.J., Brown, C.V.R. and Evans, S.L. (2021) Platelet Dysfunction after Traumatic Brain Injury: A Review. Journal of Neurotrauma, 38, 819-829. [Google Scholar] [CrossRef] [PubMed]
[34] Campbell, P.G., Sen, A., Yadla, S., Jabbour, P. and Jallo, J. (2010) Emergency Reversal of Antiplatelet Agents in Patients Presenting with an Intracranial Hemorrhage: A Clinical Review. World Neurosurgery, 74, 279-285. [Google Scholar] [CrossRef] [PubMed]
[35] ElSaadani, M., Ahmed, S.M., Jacovides, C., Lopez, A., Johnson, V.E., Kaplan, L.J., Smith, D.H. and Pascual, J.L. (2021) Post-Traumatic Brain Injury Antithrombin III Recovers Morris Water Maze Cognitive Performance, Improving Cued and Spatial Learning. Journal of Trauma and Acute Care Surgery, 91, 108-113. [Google Scholar] [CrossRef] 
[36] Lipowsky, H.H. (2012) The Endothelial Glycocalyx as a Barrier to Leukocyte Adhesion and Its Mediation by Extracellular Proteases. Annals of Biomedical Engineering, 40, 840-848. [Google Scholar] [CrossRef] [PubMed]
[37] Zou, Z., Li, L., Schäfer, N., Huang, Q., Maegele, M. and Gu, Z. (2021) Endothelial Glycocalyx in Traumatic Brain Injury Associated Coagulopathy: Potential Mechanisms and Impact. Journal of Neuroinflammation, 18, Article No. 134. [Google Scholar] [CrossRef] [PubMed]
[38] Gayet-Ageron, A., Prieto-Merino, D., Ker, K., Shakur, H., Ageron, F.X. and Roberts, I. (2018) Effect of Treatment Delay on the Effectiveness and Safety of Antifibrinolytics in Acute Severe Haemorrhage: A Meta-Analysis of Individual Patient-Level Data from 40138 Bleeding Patients. The Lancet, 391, 125-132. [Google Scholar] [CrossRef] 
[39] The CRASH-2 Collaborators (2011) The Importance of Early Treatment with Tranexamic Acid in Bleeding Trauma Patients: An Exploratory Analysis of the CRASH-2 Randomised Controlled Trial. The Lancet, 377, 1101.e1-1101.e2. [Google Scholar] [CrossRef] 
[40] Joseph, B., Hadjizacharia, P., Aziz, H., Kulvatunyou, N., Tang, A., Pandit, V., Wynne, J., O’Keeffe, T., Friese, R.S. and Rhee, P. (2013) Prothrombin Complex Concentrate: An Effective Therapy in Reversing the Coagulopathy of Traumatic Brain Injury. Journal of Trauma and Acute Care Surgery, 74, 248-253. [Google Scholar] [CrossRef] 
[41] Lombardo, S., Millar, D., Jurkovich, G.J., Coimbra, R. and Nirula, R. (2018) Factor VIIa Administration in Traumatic Brain Injury: An AAST-MITC Propensity Score Analysis. Trauma Surgery & Acute Care Open, 3, e000134. [Google Scholar] [CrossRef] [PubMed]

为你推荐